BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4649 related articles for article (PubMed ID: 4889497)

  • 1. Immunofluorescence studies of a lymphoid cell line derived from a patient with lymphocytic lymphoma.
    Trujillo JM; Shively JA; List-Young B; Gott CL
    Tex Rep Biol Med; 1969; 27(1):117-25. PubMed ID: 4889497
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour-associated antigens and tumour-host interactions.
    Baldwin RW
    Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
    [No Abstract]   [Full Text] [Related]  

  • 3. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 4. Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens.
    Fenyö EM; Klein E; Klein G; Swiech K
    J Natl Cancer Inst; 1968 Jan; 40(1):69-89. PubMed ID: 4864597
    [No Abstract]   [Full Text] [Related]  

  • 5. Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines.
    Klein G; Klein E; Clifford P
    Cancer Res; 1967 Dec; 27(12):2510-20. PubMed ID: 4866767
    [No Abstract]   [Full Text] [Related]  

  • 6. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures.
    Klein G; Clifford P; Klein E; Smith RT; Minowada J; Kourilsky FM; Burchenal JH
    J Natl Cancer Inst; 1967 Nov; 39(5):1027-44. PubMed ID: 4169243
    [No Abstract]   [Full Text] [Related]  

  • 7. Persistence of H-2 and some non-H-2 antigens on long-term-cultured mouse cell lines.
    Klein D; Merchant DJ; Klein J; Shreffler DC
    J Natl Cancer Inst; 1970 May; 44(5):1149-60. PubMed ID: 4936571
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of immunology in the treatment of leukemias and hematosarcomas.
    Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Cattan A; Schlumberger JR
    Cancer Res; 1967 Dec; 27(12):2542-53. PubMed ID: 4170385
    [No Abstract]   [Full Text] [Related]  

  • 9. An immunofluorescence study of the in vitro interaction between lymphoid cells and target cells.
    Clark JM; Weiss L
    J Immunol; 1969 Nov; 103(5):1006-13. PubMed ID: 4900516
    [No Abstract]   [Full Text] [Related]  

  • 10. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
    Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
    Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 12. Transplantability of human lymphoid cell line, lymphoma, and leukemia in splenectomized and/or irradiated nude mice.
    Watanabe S; Shimosato Y; Kuroki M; Sato Y; Nakajima T
    Cancer Res; 1980 Jul; 40(7):2588-95. PubMed ID: 6930325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-specific cytotoxic activity of the lymphocyte in vitro--role of the lymphoblast in cyto-immunology].
    Hanaoka M
    Saishin Igaku; 1969 Jul; 24(7):1469-77. PubMed ID: 4902432
    [No Abstract]   [Full Text] [Related]  

  • 14. Total cell-associated immunoglobulin (TCAI) and immunoglobulin (Ig)synthesis of human leukocytes.
    Longmire R; McMillan R; Yelenosky R; Craddock C
    Trans Assoc Am Physicians; 1971; 84():229-38. PubMed ID: 5172851
    [No Abstract]   [Full Text] [Related]  

  • 15. Mouse monoclonal antibody (WI-MN-1) against malignant melanoma.
    Khan A; Grammer S; Chang D; Hill NO; Miller J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5868-72. PubMed ID: 6196109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody defining a lymphoma-associated antigen in man.
    Nadler LM; Stashenko P; Hardy R; Schlossman SF
    J Immunol; 1980 Aug; 125(2):570-7. PubMed ID: 6156208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral cross immunity in patients with malignant tumors.
    Harlozinska A; Albert Z; Richter R; Singer Z; Salwa J
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):835-49. PubMed ID: 4946994
    [No Abstract]   [Full Text] [Related]  

  • 18. An immunofluorescent test for feline leukemia and sarcoma virus antigens and antibodies.
    Riggs JL
    J Am Vet Med Assoc; 1971 Mar; 158(6):Suppl 2:1085+. PubMed ID: 4930303
    [No Abstract]   [Full Text] [Related]  

  • 19. Phytohemagglutinin-induced changes in cultured lymphocytes in the course of some lymphoproliferative and reticuloproliferative diseases. I. Blastic transformation.
    Rozynkowa D; Kowalewski J
    Pol Med J; 1970; 9(4):847-54. PubMed ID: 5273571
    [No Abstract]   [Full Text] [Related]  

  • 20. Graft reaction in tissue culture. II. Quantification of the lytic action on mouse fibroblasts by rat lymphocytes sensitized on mouse embryo monolayers.
    Berke G; Ax W; Ginsburg H; Feldman M
    Immunology; 1969 May; 16(5):643-57. PubMed ID: 5787770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 233.